Search
Tinea Pedis caused by Trichophyton mentagrophytes
go.drugbank.com/conditions/DBCOND0121748Drugs: KetoconazoleSynonyms: Tinea Pedis caused by Trichophyton mentagrophytesAprotinin
go.drugbank.com/drugs/DB06692ApprovedInvestigationalWithdrawnThe goal of using of aprotinin was subsequently to minimize end-organ damage resulting from hypotension due to blood loss in surgery and to reduce the necessity for blood transfusions during surgery.
Peanut oil
go.drugbank.com/drugs/DB13964ApprovedWithdrawnPeanut oil is derived from Arachis hypogaea which can be found in South America, Mexico, and Centro America. The kernels are consumed roasted but a large percentage is used for the production of vegetable oil. The peanut oil represents a...
Diphenhydramine
go.drugbank.com/drugs/DB01075ApprovedInvestigationalDiphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes ...
Mixtures: Bye Bye Bite LotProducts: Dormmy-lonOtoferlin Gene-mediated Hearing Loss
go.drugbank.com/conditions/DBCOND0170571Drugs: Lunsotogene parvecSynonyms: Otoferlin Gene-mediated Hearing Loss, Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)Metastatic HER2-low Breast Cancer
go.drugbank.com/conditions/DBCOND0150505Drugs: Trastuzumab deruxtecanSynonyms: Metastatic HER2-low Breast CancerRefractory Pediatric Low-grade Gliomas
go.drugbank.com/conditions/DBCOND0165843Drugs: TovorafenibSynonyms: Refractory Pediatric Low-grade GliomasDoconexent
go.drugbank.com/drugs/DB03756ApprovedInvestigationalDHA is a 22 carbon chain with 6 cis double bonds with anti-inflammatory effects. It can be biosythesized from alpha-linolenic acid or commercially manufactured from microalgae.
Avutometinib
go.drugbank.com/drugs/DB15254ApprovedInvestigational[A273948] Avutometinib was approved by the US FDA in May 2025 in a co-package alongside [defactinib] (called Avmapki Fakzynja) for the treatment of recurrent KRAS-mutated low-grade serous ovarian cancer
Iopamidol
go.drugbank.com/drugs/DB08947ApprovedInvestigationalIopamidol is a contrast agent developed by Bracco with nonionic, low-osmolar properties.
Categories: Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media